MiNK Therapeutics (INKT) Director John Holcomb Receives RSU Award

What Happened John Bradley Holcomb, a director of MiNK Therapeutics, was granted 1,233 restricted stock units (RSUs) on 2026-09-01. The award is reported at $10.95 per share, for a total reported value of $13,501. This was a compensation award (grant), not an open-market purchase or sale.

Key Details

• Transaction date and price: 2026-09-01; recorded value $10.95 per share; total $13,501.
• Type: Award/Grant (RSUs) received in lieu of cash board and committee retainers.
• Vesting: The RSUs vest one month from the grant date (per footnote).
• Shares owned after transaction: Not specified in the filing.
• Filing timeliness: Reported 2026-09-02 for a 2026-09-01 grant — appears to be filed promptly.

Context RSUs are a contingent right to receive one share each upon vesting; they are restricted until they vest and convert to common stock. Awards given as director compensation are common and typically reflect routine pay rather than a direct trading signal. The reported value of this award is modest (~$13.5K).